Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio
January 27, 2025 07:30 ET
|
Anavex Life Sciences Corp.
Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent for Alzheimer's Disease
2024 Research: Global Invasive Ductal Carcinoma Treatment Market Set to Reach $23.02 Billion by 2034, - Rising Prevalence of Breast Cancer Fuels Advancements in Personalized Medicine
January 27, 2025 04:29 ET
|
Research and Markets
Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Invasive Ductal Carcinoma Treatment Market by Therapy, by Type, by Distribution Channel, and By Region" report has been added to ...
America’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at Prestigious Regeneron Science Talent Search
January 23, 2025 12:00 ET
|
Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y. and WASHINGTON, D.C., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) today announced the top 40 finalists in...
KULR Technology and Scripps Research Collaborate on Novel Pyrolytic Carbon Electrode Technology
January 22, 2025 08:45 ET
|
KULR Technology Group, Inc.
KULR Technology Group, Inc. (NYSE American: KULR) announced an innovative collaboration with the prestigious Scripps Research Institute's Baran Lab
Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline
January 22, 2025 08:00 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline
Cartilage Degeneration Therapy Global Research 2024-2030: Prevalence of Osteoarthritis, Expansion of Sports Medicine Driving Demand, Adoption of Biologics and Cell-Based Therapies
January 22, 2025 04:14 ET
|
Research and Markets
Dublin, Jan. 22, 2025 (GLOBE NEWSWIRE) -- The "Cartilage Degeneration Therapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Argentum 47, Inc. Announces Acquisition of Marelius Biopharma Group, Divestiture of Argentum Data Solutions, and Leadership Transition
January 21, 2025 12:00 ET
|
Argentum 47, Inc.
Announces Acquisition of Marelius Biopharma Group, Divestiture of Argentum Data Solutions, and Leadership Transition
RS BioTherapeutics Announces Positive Anti-Inflammatory and Anti-Fibrotic Effects of Lead Compound in Human Lung Tissue
January 21, 2025 10:00 ET
|
RS BioTherapeutics
CUMBERLAND, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from deadly lung diseases...
Olympia Pharmaceuticals Expands into Alabama with New Licensing, Bringing GLP-1s and More to Healthcare Providers
January 21, 2025 09:00 ET
|
Olympia Pharmaceuticals
ORLANDO, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals, a state-of-the-art, FDA-registered 503B pharmaceutical outsourcing facility, is proud to announce its expansion into...
Botanical and Plant-derived Drugs Market Research Report, 2025-2029 - Growth Opportunities for Infectious Diseases, Central Nervous System, Cardiovascular Diseases, Respiratory Diseases, and Other Applications
January 21, 2025 05:33 ET
|
Research and Markets
Dublin, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The "Botanical and Plant-derived Drugs Market 2025-2029" report has been added to ResearchAndMarkets.com's offering.The botanical and plant-derived drugs...